One of the most significant accomplishments was to show a strong inhibitory properties of human defensin 5 (HD5) against the papillomaviruses. These properties make HD5 a potential candidate for the topical agent in preventing the papillomavirus infection. This year we also published the first structural data on three human alpha-defensis, HNP4, HD5, and HD6. This accomplishments makes all human alpha-defensins structurally characterized. In the other study, we published the preliminary draft of the epitope in the human beta-defensin molecules, that is responsible for binding and/or activating the chemokine receptor, CCR6. In continuation of this effort, whcih is near-complete, we identified more details on the structural determinants of beta-defensins, whcih are necessary for productive interaction with CCR6. We also showed that one of these proteins, hBD4, does not activate CCR6 and explained, in detail, the reason for this defficiency. In collaboration with Dr. Lu, we studies two other aspects of human alpha-defensins' chemistry: high ratio of Arg (as compared to Lys) in their sequences, the phenomenon not observed for beta-defensins, and effect of the pro-region, in a pro-peptide form, for the folding efficiency of human alpha-defensins. In both cases, we provided a rationalization, based largery on structural studies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01SC010386-07
Application #
7735424
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
2008
Total Cost
$385,062
Indirect Cost
Name
National Cancer Institute Division of Clinical Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Wu, Zhibin; Li, Xiangqun; Ericksen, Bryan et al. (2007) Impact of pro segments on the folding and function of human neutrophil alpha-defensins. J Mol Biol 368:537-49
Zou, Guozhang; de Leeuw, Erik; Li, Chong et al. (2007) Toward understanding the cationicity of defensins. Arg and Lys versus their noncoded analogs. J Biol Chem 282:19653-65
Pazgier, M; Hoover, D M; Yang, D et al. (2006) Human beta-defensins. Cell Mol Life Sci 63:1294-313
Buck, Christopher B; Day, Patricia M; Thompson, Cynthia D et al. (2006) Human alpha-defensins block papillomavirus infection. Proc Natl Acad Sci U S A 103:1516-21
Pazgier, Marzena; Lubkowski, Jacek (2006) Expression and purification of recombinant human alpha-defensins in Escherichia coli. Protein Expr Purif 49:1-8
Xie, Cao; Prahl, Adam; Ericksen, Bryan et al. (2005) Reconstruction of the conserved beta-bulge in mammalian defensins using D-amino acids. J Biol Chem 280:32921-9
Economopoulou, Matina; Bdeir, Khalil; Cines, Douglas B et al. (2005) Inhibition of pathologic retinal neovascularization by alpha-defensins. Blood 106:3831-8
Wu, Zhibin; Cocchi, Fiorenza; Gentles, David et al. (2005) Human neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro. FEBS Lett 579:162-6
Yang, De; Biragyn, Arya; Hoover, David M et al. (2004) Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu Rev Immunol 22:181-215
Wu, Zhibin; Alexandratos, Jerry; Ericksen, Bryan et al. (2004) Total chemical synthesis of N-myristoylated HIV-1 matrix protein p17: structural and mechanistic implications of p17 myristoylation. Proc Natl Acad Sci U S A 101:11587-92

Showing the most recent 10 out of 12 publications